Because microRNA-mediated silencing of IGFBP5 has been shown to promote osteoporosis (49), it is possible that attenuated expression of this gene in parathyroid adenomas could contribute to bone mineral density loss in PHPT in addition to the direct osteoclastic effects of PTH. The gene discussed is IGFBP5; the disease is parathyroid gland adenoma.